Vitiligo Research Foundation

Outstanding Traditional Chinese Medicine Vitiligo Treatment Institution Establishes Itself in Shanghai, Aiming to Provide Specialized Treatment Solutions to More International Patients

Retrieved on: 
Tuesday, September 26, 2023

This significant step marks the formal expansion of the distinguished Chinese vitiligo treatment institution into key metropolitan centers.

Key Points: 
  • This significant step marks the formal expansion of the distinguished Chinese vitiligo treatment institution into key metropolitan centers.
  • Huahai's bilingual clinic caters to international patients and those with specialized treatment needs, offering them more accessible access to traditional Chinese medicine and a high caliber of medical care.
  • Shanghai, as an international metropolis, attracts patients and medical professionals from all over the world, fostering collaboration and research in the field of vitiligo treatment.
  • How does the escalating demand for vitiligo treatment in the international market influence Huahai Institute of Vitiligo Research's decisions?

Global Vitiligo Clinical Trial Pipeline Market Research Report 2021-2025: Phase 3, Phase 2, Phase 1, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Global Vitiligo Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Vitiligo Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Vitiligo Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Vitiligo market.
  • It covers emerging therapies for Vitiligo in active clinical development stages including early and late stage clinical trials.
  • The report provides Vitiligo pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Vitiligo Epidemiology and Patient Flow Research Report 2021: Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries - ResearchAndMarkets.com

Retrieved on: 
Friday, May 7, 2021

b'The "Global Vitiligo Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Vitiligo Epidemiology and Patient Flow Analysis - 2021, provides Vitiligo epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Vitiligo Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Vitiligo Epidemiology and Patient Flow Analysis - 2021, provides Vitiligo epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Vitiligo patients, history of the disease at the population level (Vitiligo prevalence, Vitiligo incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Vitiligo patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Vitiligo market sizing, assessing market potential, and developing drug forecast models\nIdentify Vitiligo patients segments through age groups, gender, and disease sub-types\n'

Vitiligo Pipeline Review, H2 2020: Overview of the Vitiligo (Dermatology) Pipeline Landscape Featuring 21 Key Players - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 25, 2021

Vitiligo - Pipeline Review, H2 2020, provides an overview of the Vitiligo (Dermatology) pipeline landscape.

Key Points: 
  • Vitiligo - Pipeline Review, H2 2020, provides an overview of the Vitiligo (Dermatology) pipeline landscape.
  • The Vitiligo (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Vitiligo and features dormant and discontinued projects.
  • The pipeline guide reviews pipeline therapeutics for Vitiligo (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide reviews key companies involved in Vitiligo (Dermatology) therapeutics and enlists all their major and minor projects.

World's Leading Biobanks Join BC Platforms Global Data Partner Network to Advance Personalized Healthcare Research

Retrieved on: 
Monday, April 6, 2020

ZURICH and BOSTON, April 6, 2020 /PRNewswire/ -- BC Platforms , a global leader in providing a powerful data and technology platform for personalized healthcare, today announced it has added three new leading biobanks to its Global Data Partner Network, BCRQUEST.com, including Generation Scotland, UK, Bialystok Biobank, Poland, and Biobank Graz Austria.

Key Points: 
  • ZURICH and BOSTON, April 6, 2020 /PRNewswire/ -- BC Platforms , a global leader in providing a powerful data and technology platform for personalized healthcare, today announced it has added three new leading biobanks to its Global Data Partner Network, BCRQUEST.com, including Generation Scotland, UK, Bialystok Biobank, Poland, and Biobank Graz Austria.
  • This will progress the development of personalized healthcare for the benefit of patients, healthcare systems and research."
  • BC Platforms is a global leader in providing a powerful data discovery and analytics platform as well as data science solutions for personalized healthcare.
  • The company has developed and supports a Global Data Partner Network BCRQUEST.com, to provide genomic and clinical cohort data for pharmaceutical and medical research and development.

World's Leading Biobanks Join BC Platforms Global Data Partner Network to Advance Personalized Healthcare Research

Retrieved on: 
Monday, April 6, 2020

ZURICH and BOSTON, April 6, 2020 /PRNewswire/ -- BC Platforms , a global leader in providing a powerful data and technology platform for personalized healthcare, today announced it has added three new leading biobanks to its Global Data Partner Network, BCRQUEST.com, including Generation Scotland, UK, Bialystok Biobank, Poland, and Biobank Graz Austria.

Key Points: 
  • ZURICH and BOSTON, April 6, 2020 /PRNewswire/ -- BC Platforms , a global leader in providing a powerful data and technology platform for personalized healthcare, today announced it has added three new leading biobanks to its Global Data Partner Network, BCRQUEST.com, including Generation Scotland, UK, Bialystok Biobank, Poland, and Biobank Graz Austria.
  • This will progress the development of personalized healthcare for the benefit of patients, healthcare systems and research."
  • BC Platforms is a global leader in providing a powerful data discovery and analytics platform as well as data science solutions for personalized healthcare.
  • The company has developed and supports a Global Data Partner Network BCRQUEST.com, to provide genomic and clinical cohort data for pharmaceutical and medical research and development.

MyHealthTeams and the Global Vitiligo Foundation Team to Bring Consumer-Relevant, Medically Reviewed Content to the Vitiligo Community

Retrieved on: 
Tuesday, March 3, 2020

Together, the two will bring relevant, trusted health education information and resources to people via MyVitiligoTeam , a social network designed just for people facing vitiligo.

Key Points: 
  • Together, the two will bring relevant, trusted health education information and resources to people via MyVitiligoTeam , a social network designed just for people facing vitiligo.
  • Launched in January 2020, more than 1,000 registered members have already joined MyVitiligoTeam, the 34th condition-specific social network created by MyHealthTeams.
  • Reflecting a shared commitment to improving quality of life for people living with vitiligo, the two organizations will create and publish medically reviewed content featured within the social network.
  • "MyVitiligoTeam and our collaboration with the Global Vitiligo Foundation changes all that.

Vitiligo Clinical Trial Pipeline Highlights 2019 - Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company - ResearchAndMarkets.com

Retrieved on: 
Friday, June 14, 2019

The "Global Vitiligo Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Vitiligo Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering.
  • Vitiligo Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Vitiligo market.
  • It covers emerging therapies for Vitiligo in active clinical development stages including early and late stage clinical trials.
  • The report provides Vitiligo pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Global Vitiligo Epidemiology Forecasts Report 2018-2027: Focus on United States, Germany, Spain, Italy, France and United Kingdom, and Japan

Retrieved on: 
Thursday, January 24, 2019

Vitiligo - Epidemiology Forecast to 2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Vitiligo in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Key Points: 
  • Vitiligo - Epidemiology Forecast to 2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Vitiligo in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
  • The Vitiligo epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries.
  • The epidemiology data for Vitiligo are studied through all possible division to give a better understanding about the Disease scenario in 7MM.
  • Prevalent Cases according to segmentation: Sex Specific cases, Type Specific Diagnosed Prevalent cases and Age Specific cases of Vitiligo